BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2019
View Archived Issues
FDA clears Wellspring's IND for KRAS G12C inhibitor ARS-3248
Read More
FOX-115 improves endurance of motor performances in aged mice
Read More
Phase I trial explores use of CAR T-cell therapy targeting claudin18.2 in advanced solid tumors
Read More
Shanghai Fosun Pharmaceutical studies MEK inhibitor FCN-159 in advanced melanoma
Read More
Design of an ATP-competitive chemical inhibitor of spastin
Read More
BNTA promotes generation of extracellular matrix components and delays osteoarthritis progression
Read More
Engineering B cells may enable skipping the vaccine
Read More
Forcing a multitasker to focus
Read More
Boosting PTEN foils Myc
Read More
Takeda presents new data for TAK-831
Read More
Preliminary phase II results show improved function with apraglutide in short bowel syndrome
Read More
Mutations in a subunit of DNA polymerase alpha-primase underlie an X-linked intellectual disability
Read More
Somatic variants in PDGFRB gene are involved in the physiopathology of fusiform cerebral aneurysm
Read More
Japanese researchers patent RyR1 channel blockers
Read More
Phase II results of ExPEC4V vaccine against extraintestinal pathogenic E. coli in healthy adults
Read More
Phase I trials of mRNA vaccines against H10N8 and H7N9 influenza viruses confirm immunogenicity
Read More
U.S. researchers present TGFR inhibitors
Read More
Yumanity Therapeutics synthesizes new SCD1 and SCD5 inhibitors
Read More
Interim analysis of INTELLANCE-1 study of Depatux-M in GBM shows no survival benefit
Read More
Merck & Co. divulges new HCV inhibitors
Read More
Genentech describes RIPK1 inhibitors
Read More
FDA approves Gattex for pediatric patients with short bowel syndrome
Read More
Travoprost implant OTX-TIC safe, improves intraocular pressure in phase I trial
Read More
New phase II trial studies TQB-2450 in relapsed or refractory classical Hodgkin's lymphoma
Read More